State of Wisconsin Investment Board’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-29,100
Closed -$114K 1780
2019
Q4
$114K Hold
29,100
﹤0.01% 1606
2019
Q3
$256K Hold
29,100
﹤0.01% 1476
2019
Q2
$269K Buy
29,100
+600
+2% +$4.52K ﹤0.01% 1459
2019
Q1
$183K Buy
28,500
+6,500
+30% +$42.3K ﹤0.01% 1470
2018
Q4
$207K Buy
22,000
+200
+0.9% +$3.01K ﹤0.01% 1454
2018
Q3
$439K Hold
21,800
﹤0.01% 1426
2018
Q2
$636K Buy
21,800
+8,800
+68% +$272K ﹤0.01% 1304
2018
Q1
$387K Hold
13,000
﹤0.01% 1343
2017
Q4
$418K Hold
13,000
﹤0.01% 1317
2017
Q3
$452K Hold
13,000
﹤0.01% 1317
2017
Q2
$387K Buy
+13,000
New +$373K ﹤0.01% 1338

Other funds holding LJPC

State of Wisconsin Investment Board's LJPC Position: Q1 2020 in Review

State of Wisconsin Investment Board sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2020, closing a stake of 29,100 shares — an estimated $114K sold.

State of Wisconsin Investment Board first reported a position in LJPC in Q2 2017 and held it in 11 quarters. The position peaked at $636K in Q2 2018. 73 funds tracked by Wall St. Rank hold LJPC as of Q1 2020.

  • State of Wisconsin Investment Board reported no remaining La Jolla Pharmaceutical Company position as of Q1 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 29,100 La Jolla Pharmaceutical Company shares in Q1 2020, an estimated $114K.
  • State of Wisconsin Investment Board first reported a position in La Jolla Pharmaceutical Company in Q2 2017 and held it in 11 quarters.
  • State of Wisconsin Investment Board's La Jolla Pharmaceutical Company position peaked at $636K in Q2 2018.
  • 73 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2020, filed 6 May 2020.